Drug profile · INN
rivastigmine
EXELON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rivastigmine (EXELON) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: transdermal. Current US regulatory status: approved.
Key facts
INN rivastigmine
Brand EXELON
Route TRANSDERMAL
Formulation FILM, EXTENDED RELEASE
ATC code N06DA03
Originator S.A.
Frequently asked questions
What is rivastigmine?
rivastigmine (EXELON) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: transdermal. Current US regulatory status: approved.
What is the brand name for rivastigmine?
EXELON is a marketed brand name for rivastigmine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rivastigmine?
rivastigmine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.